Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy. Azim A, Pini L, Khakwani Z, Kumar S, et al. Ann Allergy Asthma Immunol 2021;126:438-440.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azim A, Pini L, Khakwani Z, Kumar S, et al. Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy. Ann Allergy Asthma Immunol 2021;126:438-440.
PMID: 33453381